About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Agltm1Geno
targeted mutation 1, Genoway
MGI:5661387
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Agltm1Geno/Agltm1Geno C57BL/6J-Agltm1Geno MGI:5661390


Genotype
MGI:5661390
hm1
Allelic
Composition
Agltm1Geno/Agltm1Geno
Genetic
Background
C57BL/6J-Agltm1Geno
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Agltm1Geno mutation (0 available); any Agl mutation (83 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• increase in adult mortality within 1 year of age

behavior/neurological
• 8 month old mice perform less well on the accelerating rotarod than controls
• mice exhibit everted paws during walking resulting in a gait defect at 3 months of age
• mice exhibit significant performance variability on a treadmill with belt speed of 30 cm/s at 4 months of age and dramatic decrease in performance at 3 months of age and an inability to remain on the belt at 9 months of age
• mice however are able to execute the test with mild exercise for long distances at a belt speed of 15 cm/s for 350 m, although performance is worse than in controls

homeostasis/metabolism
• mice exhibit significant performance variability on a treadmill with belt speed of 30 cm/s at 4 months of age and dramatic decrease in performance at 3 months of age and an inability to remain on the belt at 9 months of age
• mice however are able to execute the test with mild exercise for long distances at a belt speed of 15 cm/s for 350 m, although performance is worse than in controls
• adult fed mice exhibit lower basal blood glucose levels
• however, serum triglycerides and total cholesterol levels are normal
• after 16 hours of fasting, glycemia is reduced in mutants compared to wild-type mice
• high levels in 3 and 12 month old fed mice; levels increase with age
• high levels in 3 and 12 month old fed mice; levels remain steadily higher
• high levels in 3 and 12 month old fed mice; levels increase with age
• serum CK is higher at 3 and 12 months of age
• increase in glycogen content in skeletal muscle including the diaphragm, liver, heart, and brain tissue of adults
• glycogen accumulation is seen in tongue tissue of 4 and 18 month old mice
• slight increase of glycogen content in brain frontal cortex, in the granular layer of the cerebellum adjacent to the Purkinje cell layer
• glycogen accumulation is seen in hepatocytes at 4, 8, 12, and 18 months of age
• glycogen in the liver has an abnormal structure
• glycogen granules are dispersed among the myofibrils in 4 month old muscles
• 12 month old muscle fibers contain large glycogen collections that are localized at the subsarcolemmal level and at intracytoplasmic sites and disrupt contractile units

liver/biliary system
• livers are dark red in color compared to lighter coloring in wild-type
• however, cirrhosis or adenomas are not seen and liver does not exhibit fibrosis, even in older mice
• 3 month old livers are increased to over 9% of total body weight and to 11% at 12 months of age, compared to 5 and 6% of total body weight in wild-type mice at these ages, respectively
• glycogen accumulation is seen in hepatocytes at 4, 8, 12, and 18 months of age
• glycogen in the liver has an abnormal structure
• hepatocytes appear enlarged due to glycogen deposition

muscle
• glycogen granules are dispersed among the myofibrils in 4 month old muscles
• 12 month old muscle fibers contain large glycogen collections that are localized at the subsarcolemmal level and at intracytoplasmic sites and disrupt contractile units

respiratory system
• older mice show an accelerated respiratory rate at basal conditions

skeleton
• seen in adults

nervous system
• slight increase of glycogen content in brain frontal cortex, in the granular layer of the cerebellum adjacent to the Purkinje cell layer

cardiovascular system

growth/size/body
• 3 month old livers are increased to over 9% of total body weight and to 11% at 12 months of age, compared to 5 and 6% of total body weight in wild-type mice at these ages, respectively

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
glycogen storage disease III DOID:2748 OMIM:232400
J:218471





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory